Recent Work
-
Finding an Answer to the Hepatitis C Cost Conundrum
We need to shift our treatment strategy to one that treats patients at the optimal time, thereby maximizing the treatment’s effectiveness and controlling costs for payers.
Categorized in Evidence Base -
For Vulnerable Populations, the Medicare Part D Doughnut Hole Disrupts Medication Adherence
Schaeffer Center researchers examined the impact of the Part D coverage gap on low-income and minority populations to determine if it changes individuals’ use of medications. Their findings show that the gap is particularly disruptive to minorities and low-income households.